ANRS, Emerging Infectious Diseases

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Adults

Interventions: Biological: Solo 0.3 group
Biological: Late boost CD40 alone
Biological: Solo 1 group
Biological: Late boost CD40 adjuvanted
Biological: Solo 3 group
Biological: Combi 0.3 group
Biological: Combi 1 group
Biological: Combi 3 group

First Posted Date: 2021-04-13

Last Posted Date: 2024-12-17

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 72

Registration Number: NCT04842682

Locations: 🇫🇷
Hôpital Henri Mondor, Créteil, France
🇫🇷
CIC 1417 - Hôpital Cochin, Paris, France
🇨🇭
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Phase 2

Completed

Conditions: Healthy
Immunization; Infection

Interventions: Biological: 3 doses of BNT162b2 vaccine
Biological: 2 dose of BNT162b2 vaccine

First Posted Date: 2021-04-01

Last Posted Date: 2023-12-14

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 267

Registration Number: NCT04824638

Locations: 🇫🇷
Centre de Recherche Clinique, CHU Côte de Nacre, Caen, France
🇫🇷
Service des maladies infectieuses, CHU de Caremeau, Nîmes, France
🇫🇷
CIC1417, hôpital Cochin, Paris, France

and more 8 locations

Covid-19 Vaccine Cohort in Specific Populations

Conditions: Immune Deficiency

Interventions: Biological: COVID-19 vaccine

First Posted Date: 2021-04-01

Last Posted Date: 2022-02-04

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 6920

Registration Number: NCT04824651

Locations: 🇫🇷
Cmg-Ec U1219, Bordeaux, France
🇫🇷
Paris Cochin APHP, Paris, France
🇫🇷
Nîmes CHU, Nîmes, France

Prophylaxis Vaccine Antibodies Ebola

Phase 2

Conditions: Ebola Virus Disease

Interventions: Drug: ansuvimab
Biological: Ervebo

First Posted Date: 2021-03-30

Last Posted Date: 2021-10-15

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 250

Registration Number: NCT04822376

Locations: 🇬🇳
Centre de Traitement Ebola de N'Zerekore, N'Zerekore, Guinea

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

Phase 3

Recruiting

Conditions: HIV-1-infection
Immuno-Deficiency
Tuberculosis

Interventions: Drug: Intensified TB treatment (initial phase)
Drug: WHO standard TB treatment (initial phase)

First Posted Date: 2021-02-04

Last Posted Date: 2022-09-21

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 1330

Registration Number: NCT04738812

Locations: 🇺🇬
Mbarara Regional Referral hospital, Mbarara, Uganda
🇰🇭
National Center for HIV/AIDS, Dermatology and STD (NCHADS), Phnom Penh, Cambodia
🇨🇲
Jamot Hospital, Yaoundé, Cameroon

and more 3 locations

Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals

Conditions: Covid19
Influenza -Like Illness

Interventions: Diagnostic Test: ILI and COVID-19 detection

First Posted Date: 2021-01-20

Last Posted Date: 2021-07-01

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 5400

Registration Number: NCT04716543

HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study

Completed

Conditions: Men Who Have Sex With Men
People Living With HIV

First Posted Date: 2020-12-28

Last Posted Date: 2022-07-22

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 1048

Registration Number: NCT04684758

Locations: 🇫🇷
Hôpital Pitié-Salpêtrière, AP-HP, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), INSERM 1136, Paris, France

Cohorte Nationale VIH-2

Conditions: HIV-2 Infection

First Posted Date: 2020-12-08

Last Posted Date: 2020-12-08

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 1185

Registration Number: NCT04658329

Locations: 🇫🇷
Centre Hospitalier François Quesnay, Mantes la Jolie, France
🇫🇷
Hôpital Saint André, Bordeaux, France
🇫🇷
Service de Medecine Interne Hopital Antoine Beclere, Clamart, France

and more 26 locations

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Phase 3

Completed

Conditions: Unsafe Sex
Risk-Taking

Interventions: Biological: Bexsero® vaccine

First Posted Date: 2020-10-22

Last Posted Date: 2024-07-30

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 556

Registration Number: NCT04597424

Locations: 🇫🇷
Hôpital Saint-Louis, Paris, France
🇫🇷
Hôpital Tenon, Paris, France
🇫🇷
Hôpital Necker-Enfants Malades, Paris, France

and more 6 locations

ANRS 12406 EvvA Study

Conditions: HIV-1-infection

First Posted Date: 2020-10-20

Last Posted Date: 2021-04-30

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 289

Registration Number: NCT04593979

Locations: 🇨🇲
Hôpital Laquinitie de Douala, Douala, Cameroon

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy